Biomedical applications of acridines : derivatives, syntheses, properties and biological activities with a focus on neurodegenerative diseases / Jan Ježek, Jan Hlaváček, Jaroslav Šebestík
| Medienart: |
Buch |
|---|
| Erscheinungsjahr: |
[2017] © 2017 |
|---|---|
| Erschienen: |
Cham: Springer ; 2017 © 2017 |
| Weitere Ausgaben: |
Erscheint auch als Online-Ausgabe: Biomedical applications of acridines |
|---|
| Reihe: |
Progress in drug research - volume 72 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ježek, Jan [VerfasserIn] |
|---|
| ISBN: |
|---|
| Umfang: |
xiii, 237 Seiten ; Illustrationen |
|---|
| Weitere IDs: |
9783319639529 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
897344014 |
|---|
| LEADER | 01000cam a2200265 4500 | ||
|---|---|---|---|
| 001 | 897344014 | ||
| 003 | DE-627 | ||
| 005 | 20240423192252.0 | ||
| 007 | tu | ||
| 008 | 170910s2017 sz ||||| 00| ||eng c | ||
| 020 | |a 9783319639529 |9 978-3-319-63952-9 | ||
| 024 | 3 | |a 9783319639529 | |
| 035 | |a (DE-627)897344014 | ||
| 035 | |a (DE-576)493214429 | ||
| 035 | |a (DE-599)BSZ493214429 | ||
| 035 | |a (OCoLC)1004325101 | ||
| 035 | |a (OCoLC)1004325101 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 044 | |c XA-CH | ||
| 050 | 0 | |a QP551 | |
| 050 | 0 | |a RS122 | |
| 050 | 0 | |a RS400-431 | |
| 060 | 0 | |a QV 240 | |
| 072 | 7 | |a PSB |2 bicssc | |
| 072 | 7 | |a SCI013020 |2 bisacsh | |
| 084 | |a 35.59 |2 bkl | ||
| 084 | |a 44.40 |2 bkl | ||
| 090 | |a a | ||
| 100 | 1 | |a Ježek, Jan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Biomedical applications of acridines |b derivatives, syntheses, properties and biological activities with a focus on neurodegenerative diseases |c Jan Ježek, Jan Hlaváček, Jaroslav Šebestík |
| 264 | 1 | |a Cham |b Springer |c [2017] | |
| 264 | 4 | |c © 2017 | |
| 300 | |a xiii, 237 Seiten |b Illustrationen | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 490 | 1 | |a Progress in drug research |v volume 72 | |
| 583 | 1 | |a Archivierung/Langzeitarchivierung gewährleistet |f PEBW |x XA-DE-BW |2 pdager |5 DE-31 | |
| 650 | 0 | |a Acridine | |
| 650 | 0 | |a Neurochemistry | |
| 650 | 0 | |a Pharmacology | |
| 650 | 0 | |a Bioorganic chemistry | |
| 650 | 0 | |a Medicinal chemistry | |
| 650 | 0 | |a Nucleic acids | |
| 650 | 0 | |a Proteins | |
| 650 | 0 | |a Chemistry | |
| 650 | 2 | |a Acridines | |
| 650 | 4 | |a Bioorganic Chemistry | |
| 650 | 4 | |a Bioorganic chemistry | |
| 650 | 4 | |a Chemistry | |
| 650 | 4 | |a Medicinal Chemistry | |
| 650 | 4 | |a Medicinal chemistry | |
| 650 | 4 | |a Neurochemistry | |
| 650 | 4 | |a Nucleic Acid Chemistry | |
| 650 | 4 | |a Nucleic acids | |
| 650 | 4 | |a Pharmacology | |
| 650 | 4 | |a Pharmacology/Toxicology | |
| 650 | 4 | |a Protein-Ligand Interactions | |
| 650 | 4 | |a Proteins | |
| 689 | 0 | 0 | |D s |0 (DE-588)4347531-0 |0 (DE-627)156893703 |0 (DE-576)211486922 |a Acridin |2 gnd |
| 689 | 0 | 1 | |D s |0 (DE-588)4045687-0 |0 (DE-627)104791454 |0 (DE-576)209066377 |a Pharmakologie |2 gnd |
| 689 | 0 | |5 (DE-627) | |
| 700 | 1 | |a Hlaváček, Jan |e verfasserin |4 aut | |
| 700 | 1 | |a Šebestík, Jaroslav |e verfasserin |4 aut | |
| 776 | 1 | |z 9783319639536 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |a Ježek, Jan |t Biomedical applications of acridines |d Cham : Springer |h [2017] |z 9783319639529 |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |a Ježek, Jan |t Biomedical Applications of Acridines |d Cham : Springer, 2017 |h Online-Ressource (XIII, 237 p. 79 illus., 25 illus. in color, online resource) |w (DE-627)1654861960 |w (DE-576)492998736 |z 9783319639536 |
| 830 | 0 | |a Progress in drug research |v volume 72 |9 72 |w (DE-627)130259209 |w (DE-576)015823598 |w (DE-600)556347-1 |x 0071-786X |7 ns | |
| 912 | |a GBV_ILN_22 | ||
| 912 | |a ISIL_DE-18 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_22_i04813 | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a ISIL_DE-8 | ||
| 912 | |a GBV_ILN_24_f066 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a ISIL_DE-3 | ||
| 912 | |a GBV_ILN_65_a004 | ||
| 912 | |a GBV_ILN_2001 | ||
| 912 | |a ISIL_DE-21 | ||
| 912 | |a GBV_ILN_2004 | ||
| 912 | |a ISIL_DE-25-15 | ||
| 912 | |a GBV_ILN_2008 | ||
| 912 | |a ISIL_DE-24 | ||
| 912 | |a GBV_ILN_2018 | ||
| 912 | |a ISIL_DE-31 | ||
| 935 | |i sf | ||
| 935 | |i Blocktest | ||
| 936 | b | k | |a 35.59 |j Heterocyclische Verbindungen |0 (DE-627)106417576 |
| 936 | b | k | |a 44.40 |j Pharmazie |j Pharmazeutika |0 (DE-627)106423304 |
| 951 | |a BO | ||
| 953 | |2 045F |a 572/.6 | ||
| 953 | |2 045F |a 615.19 | ||
| 980 | |2 22 |1 01 |x 0018 |b 1714529703 |c 00 |f 18/48 |d Oa 37/72 |e i |j --%%-- |k Standort: Wolf-Walter-Lesesaal, Reg. 23 |y zi04813 |z 11-10-17 | ||
| 980 | |2 24 |1 01 |x 0008 |b 1757296905 |c 00 |f 8/66 |d PKM 90-72 |e i |j --%%-- |h st |y zf066 |z 07-03-18 | ||
| 980 | |2 65 |1 01 |x 3/4 |b 1714156613 |c 00 |f Ha 4 |d VK 7200 111 |e u |j --%%-- |y ka004 |z 06-10-17 | ||
| 980 | |2 2001 |1 01 |x DE-21 |b 3272701192 |c 00 |f MST-Chemie |d Ji I 745-72.2017 |e --%%-- |j --%%-- |c 01 |f --%%-- |d phaz |e --%%-- |j --%%-- |y l01 |z 05-09-17 | ||
| 980 | |2 2004 |1 01 |x DE-25-15 |b 3272701303 |c 00 |f --%%-- |d Frei 15: Standort Frei 74, III 600/2-72 |e p |j --%%-- |k Seminarraum: 080.00 |y l01 |z 06-09-17 | ||
| 980 | |2 2008 |1 01 |x DE-24 |b 3272701389 |c 00 |f --%%-- |d 67/11166 |e --%%-- |j --%%-- |y l01 |z 27-09-17 | ||
| 980 | |2 2018 |1 01 |x DE-31 |b 3272701427 |c 00 |f --%%-- |d --%%-- |e --%%-- |j l |y l01 |z 22-09-17 | ||
| 983 | |2 22 |1 01 |x 0018 |8 00 |a H48 Oa | ||
| 983 | |2 22 |1 01 |x 0018 |8 00 |a H48 Oa | ||
| 984 | |2 22 |1 01 |x 0018 |a 108291034 | ||
| 984 | |2 65 |1 01 |x 3/4 |a 3/15$000476560 | ||
| 985 | |2 22 |1 01 |x 0018 |a h48.2017.457 | ||
| 985 | |2 65 |1 01 |x 3/4 |a 4/2017/01066 | ||
| 995 | |2 24 |1 01 |x 0008 |a st | ||
| 998 | |2 2001 |1 01 |x DE-21 |0 1709 |f 45 | ||
| 998 | |2 2004 |1 01 |x DE-25-15 |0 1736 | ||